Why is Boston Bio falling/rising?

As of 19-Aug, Boston Bio Systems Ltd's stock price is currently at 8.09, reflecting an increase of 0.27 or 3.45%. The stock has shown a positive trend today, outperforming its sector by 3.42% and reversing a decline after two consecutive days of falling prices. Over the past week, the stock has gained 2.02%, and in the last month, it has risen significantly by 11.28%, contrasting with the Sensex, which has seen a slight decline of 0.14%. However, there has been a notable decrease in investor participation, with delivery volume dropping by 69.54% compared to the five-day average, indicating a potential concern about liquidity despite the stock being liquid enough for trading.
In the broader market context, Boston Bio's recent performance has outpaced the Sensex, particularly in the short term, where it has achieved a return of 2.02% over the past week compared to the benchmark's 1.76%. This suggests that the stock is gaining traction relative to the overall market. The stock's moving averages indicate that it is performing better than the shorter-term averages but is still below the longer-term averages, which may reflect mixed investor sentiment. Overall, while the stock is experiencing a rise, the falling investor participation could signal caution among traders moving forward.